Federal contract award
75N93021P01428
AMBIS 2090785, PLANT AND ANIMAL EUKARYOTIC STRAND SPECIFIC MRNA (WOBI) SEQUENCING SERVICES, DIRECTIONAL LIBRARY PREPARATION (RRNA REMOVAL) AND NOVASEQ PE150 QTY 100 EACH AT $194 EACH PER QUOTE # NVUS2021063030
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541380 — Testing Laboratories and Services |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $9.3K |
| Current contract value | $9.3K |
| Potential contract value / ceiling | $9.3K |
| Start date | Sep 16, 2021 |
| Current end date | Sep 28, 2022 |
| Potential end date | Sep 28, 2022 |
| Latest award activity | Sep 1, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 1, 2026 | P00002 | $-10.1K | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Sep 28, 2022 | P00001 | $0 | AMBIS 2090785, PLANT AND ANIMAL EUKARYOTIC STRAND SPECIFIC MRNA (WOBI) SEQUENCING SERVICES, DIRECTIONAL LIBRARY PREPARATION (RRNA REMOVAL) AND NOVASEQ PE150; QTY 100 EACH AT $194 EACH PER QUOTE # NVUS2021063030 |
| Sep 16, 2021 | 0 | $19.4K | AMBIS 2090785, PLANT AND ANIMAL EUKARYOTIC STRAND SPECIFIC MRNA (WOBI) SEQUENCING SERVICES, DIRECTIONAL LIBRARY PREPARATION (RRNA REMOVAL) AND NOVASEQ PE150 QTY 100 EACH AT $194 EACH PER QUOTE # NVUS2021063030 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.